Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trial

Z MoodieE Andersen-NissenNicole GrunenbergOne B DintweFatima LaherE et al2025-01-252025-01-25WOS1549-1277https://hdl.handle.net/10539/43667Safety and immunogenicity of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV HVTN 107 A phase 12a randomized trialJournal Article